Newsquawk Logo

AbbVie (ABBV) says it maintains line of sight to "top tier growth", well into early next decade; driven by immunology and emerging obesity oppurtunities

ByNewsquawk Staff
Trade the TapeGet this analysis live, the moment it breaksNewsquawk's real-time dashboard delivers market-moving headlines and instant context to your desk before the rest of the market reacts.
Open Dashboard
#ABBVIE INC#ABBV.US#EQUITIES#EU SESSION#US SESSION#BIOTECHNOLOGY#BIOTECHNOLOGY (GROUP)#PHARMACEUTICALS, BIOTECHNOLOGY & LIFE SCIENCES#S&P 500 INDEX#ABBVIE INC#ABBV#US EQUITIES
Published: Updated:
Newsquawk Logo

© 2026 Newsquawk. All rights reserved.